For the Inventor, By the Inventor

Enter assignee name

Seattle, WA, United States of America

Acucela Inc.

USPTO Granted Patents = 98

CIPO Patents = 1

EPO Patents = 5

Trademarks = 9

Forward Citations = 754

Loading Chart...

Loading Chart...

62 inventors (with patents filed for the assignee):

Ryo Kubota (71 out of 72 patents)

Vladimir Aleksandrovich Kuksa (36 out of 38 patents)

Mark W Orme (33 out of 68 patents)

4. Ian L Scott (31 out of 40 patents)

5. Philip M Buscemi (30 out of 36 patents)

6. Amitava Gupta (27 out of 117 patents)

7. Feng Hong (27 out of 28 patents)

8. Anna S Gall (22 out of 33 patents)

9. Matthias Pfister (20 out of 23 patents)

10. Thomas Little (15 out of 21 patents)

11. Jennifer Lynn Gage (13 out of 33 patents)

12. Stefan Bauer (12 out of 19 patents)

13. Karim Haroud (12 out of 43 patents)

14. Thomas L Little, Jr (12 out of 26 patents)

15. Julien Sauvet (10 out of 14 patents)

Core Competencies:

Optical Coherence Tomography

Refractive Error Treatment

Myopia Progression

Electronic Spectacles

Peripheral Defocus

Hydrogel Contact Lens

Artificial Intelligence

Astigmatism Treatment

Diabetic Retinopathy

Image Projection Devices

Axial Length Measurement

Low Cost Ophthalmic Applications

98 patents: Sort by Forward Citations

1. 12474598 - Projection of defocused images on the peripheral retina to treat refractive error (2025-11-18),

2. 12427336 - Device for projecting images on the retina (2025-09-30),

3. 12396639 - Miniaturized mobile, low cost optical coherence tomography system for home based ophthalmic applications (2025-08-26),

4. 12290317 - Miniaturized mobile, low cost optical coherence tomography system for home based ophthalmic applications (2025-05-06),

5. 12232810 - Scan pattern and signal processing for optical coherence tomography (2025-02-25),

6. 12226647 - Method and apparatus for treating refractive error of the eye (2025-02-18),

7. 12216343 - Electronic case for electronic spectacles (2025-02-04),

8. 12210225 - Optical designs of electronic apparatus to decrease myopia progression (2025-01-28),

9. 12162871 - Inhibitors of VAP-1 (2024-12-10),

10. 12147092 - Supporting pillars for encapsulating a flexible PCB within a soft hydrogel contact lens (2024-11-19),

11. 12105362 - Stick on devices using peripheral defocus to treat progressive refractive error (2024-10-01),

12. 12085786 - Apparatus for the treatment of refractive error using active stimulation (2024-09-10),

13. 12037334 - Inhibitors of VAP-1 (2024-07-16),

14. 12029708 - Alkoxy compounds for disease treatment (2024-07-09),

15. 11986669 - Device for projecting images on the retina (2024-05-21),

Acucela Inc. is a clinical-stage biotechnology company specializing in the development and commercialization of innovative therapies for eye diseases. With a focus on preserving and restoring vision, Acucela's pipeline includes novel drug candidates targeting retinal diseases such as age-related macular degeneration and diabetic retinopathy. Leveraging their proprietary technologies, Acucela aims to provide much-needed treatment options for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

98 Patents

#19 in Seattle, WA

#62 in Washington

#3,716 in US

#7,680 in the World

Seattle, WA, United States of America

Acucela Inc.

Forward Citations = 754

62 inventors:

Ryo Kubota (71 out of 72 patents)

Vladimir Aleksandrovich Kuksa (36 out of 38 patents)

Mark W Orme (33 out of 68 patents)

4. Ian L Scott (31 out of 40 patents)

5. Philip M Buscemi (30 out of 36 patents)

Please report any incorrect information to support@idiyas.com

Loading…